The Latest From CureMatch
CureMatch has been highlighted in the “Startup Spotlight” of local, early-stage innovation companies in the annual CONNECT San Diego Innovation Report.
CureMatch today was mentioned in the San Diego Union-Tribune article “Innovative companies fuel region’s life sciences.” The article highlights several innovative start-ups, but SDUT biotechnology editor Bradley Fikes, focuses on the region’s life science startups and specifically, CureMartch. Read the complete article here.
CureMatch has been selected to compete in the “Five in 5 in the Hot Seat” Pitch Competition at BIOCOM DeviceFest. About CureMatch CureMatch™, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized […]
CureMatch was included in a discussion about personalized medicine in the San Diego Union-Tribune article “Making medicine more precise, accessible.” Dr. Razelle Kurzrock, Co-Founder and Chief Medical Advisor of CureMatch was quoted in the article, advocating for personalized combination therapy: “We’ve built this enormous way of doing things that we’ve been doing for decades, and […]
CureMatch was selected by the San Diego Venture Group as one of the 2016 Cool Companies! SDVG accepted 31 out of 140 applicants. The Cool Companies are companies that most prepared to raise venture funding. CureMatch noticed for a decision support system which helps oncologists select an optimal drug combination based upon the genetics of each patient’s tumor. SAN DIEGO’S […]
